A carregar...
Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
BACKGROUND: Survivin, a member of the inhibitor of apoptosis protein family, is an attractive target for cancer therapy. We have now investigated the effects of the combination of YM155, a novel small-molecule inhibitor of survivin expression, and platinum compounds (cisplatin and carboplatin) on hu...
Na minha lista:
| Formato: | Artigo |
|---|---|
| Idioma: | en |
| Publicado em: |
Nature Publishing Group
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2905296/ https://ncbi.nlm.nih.gov/pubmed/20517311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605713 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|